| Literature DB >> 23094251 |
Sang Kyun Lee1, Deok-Woo Kim, Eun-Sang Dhong, Seung-Ha Park, Eul-Sik Yoon.
Abstract
BACKGROUND: Autologous fat grafting evolved over the twentieth century to become a quick, safe, and reliable method for restoring volume. However, autologous fat grafts have some problems including uncertain viability of the grafted fat and a low rate of graft survival. To overcome the problems associated with autologous fat grafts, we used uncultured adipose tissue-derived stromal cell (stromal vascular fraction, SVF) assisted autologous fat grafting. Thus, the purpose of this study was to evaluate the effect of SVF in a clinical trial.Entities:
Keywords: Adipose tissue; Cell transplants; Mesenchymal stem cells; Tissue grafts
Year: 2012 PMID: 23094251 PMCID: PMC3474412 DOI: 10.5999/aps.2012.39.5.534
Source DB: PubMed Journal: Arch Plast Surg ISSN: 2234-6163
Age distribution of the patients
Fig. 1Questionnaires for the results evaluation
Each category has an evaluation score between 1 and 10, with a higher score indicating a better outcome.
Surgical outcome on malar eminence as evaluated by the patients
a)Wilcoxon signed-rank test was used for the statistical processing of the results.
Surgical outcome on nasolabial fold as evaluated by the patients
a)Wilcoxon signed-rank test was used for the statistical processing of the results.
Surgical outcome on malar eminence as evaluated by a separate surgeon
a)Wilcoxon signed-rank test was used for the statistical processing of the results.
Surgical outcome on nasolabial fold as evaluated by a separate surgeon
a)Wilcoxon signed-rank test was used for the statistical processing of the results.
Surgical outcome on nasolabial fold versus malar eminence and infraorbital region as evaluated by the patients
a)Wilcoxon signed-rank test was used for the statistical processing of the results.
Surgical outcome on nasolabial fold versus malar eminence and infraorbital region as evaluated by a separate surgeon
a)Wilcoxon signed-rank test was used for the statistical processing of the results.
Fig. 2Fat graft with SVF cells (case 1)
(A, B) Improved nasolabial fold, malar eminence, and infraorbital region after a fat graft with SVF cells (left face) or a fat graft without SVF cells (right face). The left face showed the better result. (A) Preoperative view. (B) Postoperative view at 12 weeks. (C, D) Facial bone computed tomography. Improved nasolabial fold region after a fat graft with SVF cells (left face) or a fat graft without SVF cells (right face). (C) Preoperative view. (D) Postoperative view at 12 weeks. SVF, stromal vascular fraction.
Fig. 3Fat graft with SVF cells (case 2)
Improved nasolabial fold, malar eminence, and infraorbital region after a fat graft with SVF cells (left face) or a fat graft without SVF cells (right face). The left face showed the better result. (A) Preoperative view. (B) Postoperative view at 12 weeks. SVF, stromal vascular fraction.
Surgical outcome on infraorbital region as evaluated by the patients
a)Wilcoxon signed-rank test was used for the statistical processing of the results.
Surgical outcome on infraorbital region as evaluated by a separate surgeon
a)Wilcoxon signed-rank test was used for the statistical processing of the results.